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Background: The aim of the study was to identify whether a standard supervised 
exercise programme (SEP) for patients with intermittent claudication improved 
specific measures of functional performance including balance. 
Methods: A prospective observational study was performed at a single tertiary 
vascular centre. Patients with symptomatic intermittent claudication (Rutherford 
grades 1–3) were recruited to the study. Participants were assessed at baseline (before 
SEP) and 3, 6 and 12 months afterwards for markers of lower limb ischaemia 
(treadmill walking distance and ankle : brachial pressure index), physical function (6-
min walk, Timed Up and Go test, and Short Physical Performance Battery (SPPB) 
score), balance impairment using computerized dynamic posturography with the 
Sensory Organization Test (SOT), and quality of life (VascuQoL and Short Form 36). 
Results: Fifty-one participants underwent SEP, which significantly improved initial 
treadmill walking distance (P = 0.001). Enrolment in a SEP also resulted in 
improvements in physical function as determined by 6-min maximum walking 
distance (P = 0.006), SPPB (P < 0.001), and some domains of both generic (bodily 
pain, P = 0.025) and disease-specific (social domain, P = 0.039) quality of life. 
Significant improvements were also noted in balance, as determined by the SOT 
(P < 0.001). 
Conclusion: Supervised exercise improves both physical function and balance 
impairment. 
  
+A: Introduction 
Intermittent claudication is a chronic debilitating condition predominantly affecting 
older patients, in which the main symptom is reduced walking ability. Other 
impairments include poorer overall physical function1-4, quality of life (QoL) and 
balance5,6. Recent guidance on peripheral arterial disease issued by the National 
Institute of Health and Care Excellence (NICE)5 states that all patients with 
intermittent claudication should be offered participation in an exercise programme. 
This is supported by a number of studies7-11 that show exercise improves walking 
distances and QoL, and raises levels of daily activity, reducing functional decline and 
associated morbidity and mortality in the mid to long term12-14. There is increasing 
evidence that patients with claudication have associated balance impairment15,16, 
predisposing to an increased risk of falls with associated physical and socioeconomic 
consequences6,17,18. The effect of a supervised exercise programme (SEP) on such 
outcomes has not yet been investigated. The present study investigated the role of a 
standard SEP on measures of overall physical function, including balance, for up to 
12 months afterwards. 
+A: Methods 
This prospective longitudinal study was performed at a single academic surgical 
vascular unit of a university hospital. All participants provided written informed 
consent and were recruited in accordance with the Declaration of Helsinki. Ethical 
approval for the study was gained from the local research ethics committee 
(07/Q1105/12, 07/Q1105/13, 07/H1305/83). 
Patients with claudication were identified at outpatient clinics by a consultant 
vascular surgeon, and those suitable for SEP were subsequently invited to participate 
 in the study. Data were collected prospectively at baseline and at 3, 6 and 12 months 
after supervised exercise. 
+B: Inclusion and exclusion criteria 
Claudication was determined by documented current symptoms of intermittent 
claudication with either an ankle : brachial pressure index (ABPI) of 0.9 or less, or 
drop in ankle pressure of more than 20 mmHg after exercise testing, or documented 
haemodynamically significant atherosclerosis on radiological imaging (angiography 
or Duplex ultrasonography). Other inclusion criteria included: living independently in 
the local community; no assistance required for general activities of daily living, 
including shopping, cleaning and self-care; age over 50 years; English speaking; and 
able to comply with simple study protocol instructions. 
Patients were excluded if they: were unable to perform balance testing safely 
and to comply with the study protocol as determined by the referring consultant or 
study doctor; had significant peripheral neuropathy (Toronto clinical neuropathy 
score14 of 8 or more); had a life-limiting condition (such as active cancer); had 
mobility problems (such as leg amputation, wheelchair use or hemiplegia); or suffered 
dementia. 
+B: Assessments 
On enrolment into the study, each patient underwent the following assessments, which 
were repeated 3, 6 and 12 months after supervised exercise. 
+C: Clinical indicators of lower limb ischaemia 
A constant load treadmill test (2.5 km/h) with a 10° incline was performed for a 
maximum of 5 min. ABPI was calculated before and after exercise using a hand-held 
Doppler (Ultrasonic Doppler  Flow Detector Model 811-B, Parks Medical 
Electronics, Aloha, Oregon, USA). Initial claudication distance (ICD; the distance at 
 which symptoms of ischaemic lower-limb muscle pain began) and maximum walking 
distance (MWD; the distance at which the patient could not walk any further) were 
calculated, and disease severity was determined using the Rutherford claudication 
grade19,20. 
The 6-min walk test was performed. Patients were asked to walk at their usual 
pace continually over a 20-m path. They were instructed to cover as much ground as 
possible during 6 min at a self-selected comfortable pace. MWD was recorded to the 
nearest 5 m1,2,21,22. 
+C: Assessment of physical ability 
Data were collected from the usual paced 4-m walk, the chair stand test and semi-
tandem/tandem balance tests to derive scores for the Short Physical Performance 
Battery (SPPB), a global measure of lower-limb physical function5,23-25. Patients were 
assigned a score of zero for each task they were unable to complete and scores of 1–4 
for the remaining tasks, based upon quartiles of performance for over 6000 patients in 
the Established Populations for the Epidemiologic Study of the Elderly. Patients’ 
scores were then added to obtain an overall score of between 0 and 127,26. 
For the 4-m walk test, the time taken to walk in a straight line for 4 m was 
measured in seconds, and walking velocity in metres per second was calculated. 
Patients were asked to walk at their ‘usual’ and then their ‘fastest’ pace. Each walk 
was performed twice, and the faster times were used for analysis. 
For the chair stand test, patients were asked to sit in a straight-backed chair 
(approximate seat height 42 cm) with their arms folded across their chest, and were 
requested to stand up and sit down five times, as quickly as possible. The total time 
taken to complete five chair stands was measured in seconds. This test was repeated 
after 3 min and the mean score calculated. 
 For semi-tandem and full-tandem stance, the ability to maintain a tandem or 
semi-tandem stance for 10 s was documented. The semi-tandem position required the 
feet to be parallel, with the toes of one foot adjacent to and touching the heel of the 
opposite foot. The full-tandem stance position requires one foot to be completely in 
front of the other but touching heel to toe. 
In addition, each patient underwent the Timed Up and Go (TUG) test and a hand 
grip strength test. The TUG test is a simple assessment of the risk of falls12,27,28. 
During the TUG test the patient was observed and timed as they rose from a standard 
chair (seat height 46 cm, arm height 65 cm), walked 3 m, turned around, walked back 
to the chair and resumed a seated position. 
The hand grip strength test was performed on the dominant arm using a hand 
dynamometer  (T.K.K.5401 grip – D digital hand grip gauge, Takei Digital Display, 
Takei Kogyo, Tokyo, Japan). Whilst sitting, individuals were asked to extend their 
elbow and grip the dynamometer as hard as they could for 5 s. The test was repeated 
three times and the mean score calculated for the dominant arm14,15. 
+C: Balance 
Computerized dynamic posturography was used to assess balance objectively. The 
Sensory Organization Test (SOT) was performed using the EquiTest® system 
(NeuroCom® International, Clackamas, Oregon, USA). This system comprises a 
standing platform with dual force plates, which can undergo angular rotation in the 
anterior–posterior direction (toes up versus toes down), termed ‘sway-referenced 
support’. Movement of the brightly coloured visual surround, equally capable of 
movement in the anterior–posterior direction, was termed ‘sway-referenced surround’. 
The SOT has been described previously17,18; briefly, it assesses the ability to cope 
with six different conditions to test balance during static, dynamic and sensory 
 conflicting conditions. Each condition was repeated three times, and the mean data 
were used. Sensory conflicting situations were created by movement of the visual 
surround or standing platform in response to the patient’s sway (calibrated sway-
referencing) either with, or without visual input (eyes open or closed). 
Data were collected and analysed using NeuroCom® International software 
(NeuroCom® system version 8.1.0, 1996–2006) and compared with values for healthy 
controls (who had no symptoms or history of disequilibrium or motor problems) from 
the NeuroCom® normative database. Data were stratified into three age groups: 20–
59, 60–69 and 70–79 years. The scores for patients aged over 79 years were compared 
with those of the 70–79 years age group controls owing to lack of older age data. 
Scores for SOT that fell outside those obtained by 95 per cent of controls (below the 
fifth percentile) were described as abnormal. 
+C: Assessment of patient-reported quality of life 
All patients completed a generic Short Form 36 (SF-36®; QualityMetric, Lincoln, 
Rhode Island, USA) QoL questionnaire19 and the disease-specific King’s College 
Hospital Vascular Quality of Life Questionnaire (VascuQoL)21,22 The generic SF-36® 
has been used extensively in vascular patients23-25. The VascuQoL is a validated QoL 
tool that measures disease-specific QoL for patients with Rutherford grade 1–5 
peripheral vascular disease. 
+B: Supervised exercise programme 
The SEP took place on three afternoons per week for 12 weeks (total course 36 
sessions per patient) from the baseline to 3-month visit. If patients missed a session 
due to illness or holiday they were allowed to make up the sessions at the end of the 
course. Each session lasted for a minimum of 30 min. SEP was conducted in groups 
of up to 12 patients and attendance was recorded. The SEP is described in Fig. S1 
 (supporting information); all exercises were performed at low intensity. The SEP was 
originally designed according to level 1 recommendations regarding exercise 
rehabilitation programmes for the treatment of claudication26,29. This circuit training 
format focused specifically on increasing lower limb strength and endurance, and has 
been clearly demonstrated to be clinically and cost effective in the treatment of 
claudication27,28,30,31. There are some similarities with balance-focused rehabilitation 
programmes, but no specific adaptations were made to the original SEP. 
+B: Statistical analysis 
Data sets were analysed using SPSS® version 19 (IBM, Armonk, New York, USA). A 
P value of ≤ 0.050 was used to determine significant differences in the data set. Data 
were analysed on an intention-to-treat basis. Intragroup analysis was performed using 
Friedman analysis of variance (ANOVA) for continuous data and the χ2 test for 
categorical data. Where the χ2 test had inadequate numbers within each category, i.e. 
one cell less than 20% of the total, it was not used. Instead a likelihood ratio was used 
instead.  
Sample size was calculated based on the composite equilibrium score from the 
SOT of the EquiTest® system. Owing to a lack of data on which to base a power 
calculation, initial pilot data from 19 patients with a mean(s.d.) baseline SOT score of 
65.3(12.5) per cent was used. The minimum expected clinically significant 
improvement chosen was a score of 72.9(5.4) per cent, which represented the lowest 
normal mean score for NeuroCom® healthy controls in the 70–79 years age category. 
The calculated sample size was 29 subjects, based on 90 per cent power to detect this 
difference in the SOT means (difference of 7.5) using a paired t test with a 0.05 two-
tailed significance level. Assuming a 25 per cent drop-out rate, the target group size 
was 40. 
 The initial estimate was a 25 per cent drop-out rate, but it became evident early 
in the study that the drop-out rate was significantly higher (40 per cent). The sample 
size was therefore increased to 50. 
+A: Results 
Fifty-six patients were recruited for SEP, of whom five had a Toronto (neuropathy) 
score of 8 or above and were excluded from further analysis. The 51 eligible patients 
had a median age of 69 (i.q.r. 64–75) years, and 34 (67 per cent) were men. Their 
median height was 167 cm; median weight was 78 kg and median body mass index 
27.5 kg/m2. Twenty-one patients who underwent SEP were lost during follow-up 
(Fig. 1). Patient co-morbidities are shown in Table 1; there were no differences 
between patients who attended all follow-up assessments and those who withdrew 
from the study. 
+B: Markers of claudication 
ABPI before and after exercise did not change significantly following the SEP. 
Significant improvements were seen for ICD (baseline 49.0 m versus 64.0 m at 
12 months; P = 0.001) but not for MWD (baseline 100.6 m versus 113.5 m at 
12 months; P = 0.411 ) (Table 2). 
+B: Markers of physical function 
Six-minute MWD improved following the SEP: baseline 320.0 m, which improved 
and then returned to 320 m at 12 m (P = 0.006). The median SPPB score had 
improved from 7.5 to 10 by 12 months (P < 0.001). The time taken to complete the 
TUG test (baseline 8.68 s versus 7.58 s at 12 months; P = 0.199) and hand grip 
strength (baseline 30.9 kg versus 31.3 kg at 12 months; P = 0.413) remained unaltered 
over the study interval (Table 2). 
 +B: Quality-of-life analysis 
Generic QoL improved in only one domain on the SF-36® over the 12 months of the 
study. Bodily pain (baseline value 41.0) increased after 3 months and then gradually 
declined back to baseline at 12 months (P = 0.025). The improvement in disease-
specific QoL was evident only in the social domain (P = 0.039) (Table S2, supporting 
information). 
+B: Balance 
The tandem stance time did not improve over the 12 months of the study (P = 0.126) 
(Table 3). The composite SOT score improved significantly from 63.5 to 74.5 over 
the 12 months (P < 0.001) and was associated with an increasing proportion of 
patients passing the SOT (44 per cent at baseline versus 87 per cent at 12 months) 
when compared with normalized data (likelihood ratio 4.491, d.f. 1 P = 0.034). 
+A: Discussion 
This study shows that enrolment in a SEP improves walking distance and overall 
markers of physical function. Furthermore, it suggests that a SEP can improve balance 
in patients with claudication. A parallel study31 assessing the role of percutaneous 
transluminal angioplasty for claudication showed no effect on balance. This suggests 
that exercise training delivers added benefits not seen after revascularization alone. 
The positive effect of exercise training on balance has been noted previously, 
and similar exercises are included in falls rehabilitation programmes. Current 
recommendations for balance training and falls prevention include tai chi, gait 
training and strength building32. Supervised exercise includes predominantly leg-
strengthening exercises. Only one station in the present SEP focused specifically on 
 balance (standing knee bends). 
It is not clear which aspect of the SEP improved balance in the present cohort of 
patients. Balance improvement was maintained 1 year after supervised exercise; this 
was not mirrored by improvements in walking ability. The present observation 
remains unsupported by other data on balance or falls in patients with claudication. 
Previous work from the authors’ unit suggested that abnormal balance is associated 
with central sensorineural disturbance that may be corrected by exercise. A further 
possibility is that of local improvement in lower limb function, including muscle 
strength. Hand grip strength and TUG did not improve over time here, yet there were 
improvements in the SPPB, which is in part a surrogate marker of lower limb 
strength. It is likely that sedentary behaviour is associated with leg muscle 
atrophy14,32,33. Although the nature of this study did not provide control subjects, all 
balance test results were compared with normal population data. 
The improvements in walking distance and QoL were less marked than in other 
studies of supervised exercise34 35 36 37. 
The majority of patients included in this study had Rutherford grade 2 or 3 
claudication, and were thus more severely affected than those normally seen in a SEP. 
Other studies may have focused on patients with unilateral claudication who were 
amenable for angioplasty29, had less severe claudication and could complete a 5-min 
treadmill test30,31, or were able to walk at a faster speed of 3.2 km/h32,33 compared 
with the 2.5 km/h in the present study. These are potential confounding factors that 
may have influenced the high drop-out rate of 41 per cent associated with SEP in the 
present study. 
 Enrolment in a SEP is now recommended as first-line treatment for suitable 
patients with claudication in the UK38,39. There is still debate as to the optimal method 
of delivering a SEP. This study suggests that exercise also improves overall physical 
ability and balance, which is also likely to reduce the subsequent risk of falls. 
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<TYPESETTER: Please set Fig. 1 across 1 column in usual style for flow charts> 
Fig. 1 Flow chart demonstrating follow-up in the study. Patients who did not attend 
missed only one of the follow-up appointments 
 
 Table 1 Demographics at baseline for patients who attended the supervised exercise programme and 
follow-up, and for those who did not attend the 12-month follow-up 
 
Attended follow-up (n = 30) 
Failed to attend 12-month 
follow-up (n = 21) P† 
Age (years)* 71 (65–74) 68 (64–75) 0.666 
Sex ratio (M : F) 24 : 6 10 : 11 0.016‡ 
Rutherford claudication 
grade 
  0.044§ 
1 (mild) 0 1  
2 (moderate) 19 7  
3 (severe) 10 13  
Medical history    
Ischaemic heart disease  13 8 0.708‡ 
Hypertension  22 18 0.383§ 
On statin therapy  26 18 0.923§ 
Stroke or TIA 4 4 0.302§ 
Diabetes 9 5 0.626‡ 
Smoker   0.275§ 
Current 8 6  
Ex-smoker 14 13  
Height (cm)* 167.3 (165.0–173.5) 166.0 (161.0–173.0) 0.363 
Weight (kg)* 80.0 (74.5–86.3) 76.5 (67.5–85.5) 0.518 
Body mass index (kg/m2) 28.2 (26.0–32.2) 27.1 (25.4–29.3) 0.724 
ABPI (worst leg)*    
Before exercise  0.64 (0.53–0.86) 0.58 (0.49–0.77) 0.329 
After exercise 0.34 (0.22–0.51) 0.26 (0.20–0.43) 0.360 
Treadmill ICD* 50.0 (28.9–72.5) 46.5 (31.5–62.7) 0.983 
Treadmill MWD* 107.3 (59.0–150.0) 90.1 (53.0–107.0) 0.146 
*Values are median (i.q.r.). TIA, transient ischaemic attack; ABPI, ankle : brachial pressure index; 
ICD, initial claudication distance; MWD, maximum walking distance. †Mann–Whitney U test, except 
‡χ2 test and §likelihood ratio. 
 Table 2 Changes in markers of lower-limb ischaemia and physical function over 12 months after 
supervised exercise 
 No. of 
patients Baseline 3 months 6 months 12 months P* 
Pre-exercise ABPI 24 0.64 (0.53–
0.86) 
0.69 (0.47–
0.85) 
0.64 (0.54–
0.80) 
0.66 (0.51–
0.82) 
0.731 
Postexercise ABPI 23 0.38 (0.26–
0.53) 
0.30 (0.21–
0.46) 
0.33 (0.20–
0.48) 
0.43 (0.25–
0.57) 
0.040 
Treadmill ICD (m) 21 49.0 (26.4–
66.9) 
58.0 (47.0–
74.0) 
59.0 (42.5–
106.0) 
64.0 (43.2–
92.5) 
0.001 
Treadmill MWD 
(m) 
24 100.6 
(54.8–
145.0) 
108.0 
(71.2–
193.8) 
123.5 
(70.5–
205.0) 
113.5 (67.5–
154.5) 
0.411 
6-min MWD (m) 23 320.0 
(240.0–
420.0) 
420.0 
(360.0–
460.0) 
385.0 
(280.0–
480.0) 
320.0 
(240.0–
420.0) 
0.006 
Dominant hand grip 
strength (kg) 
18 30.9 (24.5–
38.8) 
30.8 (26.6–
38.0) 
30.4 (24.2–
39.4) 
31.3 (26.3–
37.8) 
0.413 
Short Physical 
Performance 
Battery score 
25 7.5 (9–10) 11 (10–12) 11 (10–12) 10 (9–12) < 0.001 
Timed Up and Go 
test (s) 
24 8.68 (7.52–
9.73) 
7.97 (7.17–
9.53) 
7.75 (6.67–
9.66) 
7.58 (6.11–
10.03) 
0.199 
Values are median (i.q.r.). ABPI, ankle : brachial pressure index; ICD, initial claudication distance; 
MWD, maximum walking distance. *Friedman’s ANOVA. 
 
 Table 3 Changes in markers of balance over 12 months after supervised exercise 
 Baseline 3 months 6 months 12 months P* 
Passed SOT 22 of 50 (44) 34 of 49 (69) 26 of 35 (74) 26 of 30 (87)  
Composite SOT (n = 22) 63.5 (52.8–
74.0) 
72.0 (62.0–
79.3) 
73.0 (65.5–
78.0) 
74.5 (69.0–
78.5) 
< 0.001 
Tandem stance time (s) 
(n = 24) 
30.0 (21.9–
30.0) 
30.0 (30.0–
30.0) 
30.0 (30.0–
30.0) 
30.0 (21.2–
30.0) 
0.126 
Values are median (i.q.r.). SOT, Sensory Organization Test. * Friedman’s ANOVA. 
 
 
 
